MARC Record from marc_columbia

LEADER: 02491cam a2200517 a 4500
001 3952242
005 20221027005315.0
008 900823s1990 nyua b 101 0 eng c
010 $a 90012358
020 $a0471568295 (pt. A)
020 $a0471568309 (pt. B)
035 $a(OCoLC)35881515
035 $a(OCoLC)ocm35881515
035 $a(CStRLIN)NYCM90-B2980
035 $9AEQ5503HS
035 $a(NNC)3952242
035 $a3952242
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M
050 00 $aRC270.8$b.I534 1989
060 0 $aW1 PR668E v. 354$aQZ 267 I6174e 1989
082 00 $a616.99/4061$220
111 2 $aInternational Symposium on the Effects of Therapy on the Biology and Kinetics of the Surviving Tumor$d(1989 :$cVancouver, B.C.)$0http://id.loc.gov/authorities/names/n89108519
245 10 $aEffects of therapy on biology and kinetics of the residual tumor :$bproceedings of an International Symposium on the Effects of Therapy on the Biology and Kinetics of the Surviving Tumor, held in Vancouver, British Columbia, Canada, February 15-18, 1989 /$ceditors, Joseph Ragaz [and others].
260 $aNew York :$bWiley-Liss,$c1990.
300 $a2 volumes :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aProgress in clinical and biological research ;$vv. 354A-B
504 $aIncludes bibliographical references.
500 $aIncludes index.
505 0 $apt. A. Pre-clinical aspects -- pt. B. Clinical aspects.
650 0 $aCancer$xTreatment$xComplications$vCongresses.
650 0 $aTumors$xGrowth$vCongresses.
650 0 $aMetastasis$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2010101577
650 0 $aCancer$xAdjuvant treatment$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2008005053
650 2 $aAntineoplastic Agents$xadverse effects.$0https://id.nlm.nih.gov/mesh/D000970Q000009
650 2 $aAntineoplastic Agents$xpharmacokinetics.$0https://id.nlm.nih.gov/mesh/D000970Q000493
650 2 $aNeoplasm Metastasis$xetiology.
650 2 $aNeoplasms$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009369Q000188
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aRagaz, J.$q(Joseph),$d1945-$0http://id.loc.gov/authorities/names/n85334685
830 0 $aProgress in clinical and biological research ;$vv. 354A-B.
852 01 $boff,hsl$hRC270.8$i.I534 1989
866 30 $80$av. 1
852 01 $boff,hsl$hRC270.8$i.I534 1989
866 30 $80$av. 2